video

Source: The Epoch Times

On July 31, the China Central Television attacked the role of Hydroxychloroquine as treatment against the CCP Virus, and labeled President Trump’s message of the effectiveness of Hydroxychloroquine as misinformation.

That same day, Li-Meng Yan, a Chinese virologist who fled to the United States, broke the news that senior CCP officials had long known the efficacy of Hydroxychloroquine and had been taking it for prevention.




Related: Two-Tiered Medicine: Why Is Hydroxychloroquine Being Censored and Politicized?

Another 10,000 doctors reinforce support for hydroxychloroquine against Covid-19, politics can not be above life

Henry Ford Health Defends Study, Shows Hydroxychloroquine Does Reduce Death Rates

An Effective COVID Treatment the Media Continues to Besmirch

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »